Drug recall

Estriol, USP, (Micronized), 0.06 g, Distributed by Enovachem Pharmaceuticals, Torrance CA; NCD #76420-049-36

FDA recall event 84550 · Class II · Asclemed USA Inc. dba Enovachem Pharmaceuticals

Key facts

Event ID 84550
Recall numbers D-0650-2020, D-0651-2020, D-0652-2020
Recalling firm Asclemed USA Inc. dba Enovachem Pharmaceuticals
Product type Drugs
Products Estriol, USP, (Micronized), 0.06 g, Distributed by Enovachem Pharmaceuticals, Torrance CA; NCD #76420-049-36, Estriol, USP, (Micronized), 0.12 g, Distributed by Enovachem Pharmaceuticals, Torrance CA; NCD #76420-049-37, Estriol, USP, (Micronized), 0.24 g, Distributed by Enovachem Pharmaceuticals, Torrance CA; NCD #76420-049-38
Classification Class II
Status Terminated
Voluntary or mandated Voluntary: Firm Initiated
Reason for recall Failed Impurities/Degradation Specifications: Additional testing found Out of Specification impurity test results.
Initiation date Dec 9, 2019
Report date Jan 15, 2020
Termination date Aug 9, 2023
City Torrance
State CA
Country United States
FEI number 3001452204

At a glance

  • 1–9 Products in this recall
  • 1–9 FDA inspections of this firm (FEI)

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA drug and product recalls

FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.

Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date:

Browse all FDA drug and product recalls